$132.75
-11.74-8.13%
Last update: Oct 16, 7:39 PM
$131.00
-13.49-9.34%
Twist Bioscience Corp
TWSTNASDAQ
Twist Bioscience (TWST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Twist Bioscience (TWST) last issued guidance on August 3, 2026 for fiscal year 2026. The company guided revenue in the range of $456M - $457M for the period.
Compared to prior guidance, Twist Bioscience raised its revenue forecast from a prior range of $442M - $447M.
Twist Bioscience has issued 38 guidance updates between November 18, 2022 and August 3, 2026. During this period, the company raised its outlook 16 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.53 | $-0.50 | $-0.46 |
| Actual | $-0.56 | $-0.59 | $-0.50 | $-0.45 |
| Surprise | -133.3% | -11.3% | 0.00% | +2.17% |
| Revenue | ||||
| Estimate | $114.5M | $107.7M | $102.7M | $97.4M |
| Actual | $118.4M | $110.7M | $103.7M | $99.0M |
| Surprise | +3.36% | +2.80% | +0.95% | +1.69% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.25 | $-0.19 | $-0.47 | $-0.41 |
| Revenue | ||||
| Consensus | $123.5M | $126.3M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 3, 2026 | $-0.56 | $-0.24 | -133.3 % |
| Q2 | May 4, 2026 | $-0.59 | $-0.53 | -11.3 % |
| Q1 | Feb 2, 2026 | $-0.50 | $-0.50 | 0.00 % |
| Q4 | Nov 14, 2025 | $-0.45 | $-0.46 | 2.17 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 3, 2026 | $118.38M | $114.53M | 3.36 % |
| Q2 | May 4, 2026 | $110.72M | $107.70M | 2.80 % |
| Q1 | Feb 2, 2026 | $103.70M | $102.72M | 0.95 % |
| Q4 | Nov 14, 2025 | $99.01M | $97.37M | 1.69 % |
